Journal of Reconstructive Urology

.: ORIGINAL RESEARCH
The Effect of Intravesical OnabotulinumtoxinA Injection on Women Sexual Function in Overactive Bladder Treatment: Observational Study
Aşırı Aktif Mesane Tedavisinde Kullanılan İntravezikal OnabotulinumtoksinA Enjeksiyonunun Kadın Cinsel Fonksiyonu Üzerindeki Etkisi: Gözlemsel Çalışma
Erkan MERDERa, Mehmet Gökhan ÇULHAa, Ahmet ARIMANa, Bahadır ERMEÇa, Murat ÖZERa, Fatih ALTUNRENDEa
aDepartment of Urology, University of Health Sciences Prof. Dr. Cemil Taşcıoğlu City Hospital, İstanbul, TURKEY
J Reconstr Urol. 2021;11(2):79-83
doi: 10.5336/urology.2021-82624
Article Language: EN
Full Text
ABSTRACT
Objective: To investigate the effect of intravesical onabotulinumtoxinA (Botox) injection on female sexual function in women with overactive bladder (OAB) and to evaluate its relationship with OAB symptoms. Material and Methods: Data from 56 patients with idiopathic OAB and who were resistant to medical therapy between January 2018 and July 2019 were evaluated. The patients were evaluated with an overactive bladder symptom score (OABSS) and female sexual function index (FSFI) before and after 100 IU Botox treatment. The changes in the symptom scores of the patients and the FSFI scores were compared. Results: A total of 38 patients completed the study. The mean age of the patients was 41.59±11.79 (31-56), and the mean body mass index was 30.02±4.77 kg/m2. Mean duration of complaints was 48,93±45,32 months and mean number of pads daily used was 3,92±2,39. For the treatment of idiopathic OAB, 100IU Botox application to each patient was performed in 20 regions. Significant improvement was observed in the OABSS scores of the patients 12 weeks after treatment (10.32±3.01 to 4.68±2.21; p<0.001). When the FSFI scores were examined, a significant improvement was observed in the FSFI-desire, arousal, satisfaction, and pain subgroups and total FSFI score 12 weeks after the procedure. In the post-treatment evaluation, 94.73% of the patients were satisfied with the treatment. Urinary retention occurred in two patients. Conclusion: As a result of our study, intravesical botox injections have been shown to improve sexual function in women with OAB. More extensive studies are needed to better evaluate the effects of botox injection on sexual functions.

Keywords: Overactive bladder; botox; female sexual function; urge urinary incontinence
ÖZET
Amaç: Aşırı aktif mesane (AAM) semptomları kadın cinsel fonksiyonu üzerinde olumsuz bir etkiye sahiptir. Bu çalışmanın amacı, AAM'li kadınlarda intravezikal onabotulinumtoksinA (Botoks) enjeksiyonunun kadın cinsel fonksiyonu üzerindeki etkisini araştırmak ve AAM semptomları ile ilişkisini değerlendirmektir. Gereç ve Yöntemler: Ocak 2018-Temmuz 2019 tarihleri arasında idiopatik AAM tanısı olan ve medikal tedaviye dirençli 56 hastanın verileri değerlendirildi. Hastalar 100 IU Botoks tedavisi öncesi ve tedaviden 12 hafta sonra aşırı aktif mesane semptom skoru (OABSS) ve kadın cinsel fonksiyon indeksi [female sexual function index (FSFI)] ile değerlendirildi. Hastaların semptom skorlarındaki değişiklikler ile FSFI skorları arasındaki değişiklikler karşılaştırıldı. Bulgular: Çalışmayı 38 hasta tamamladı. Hastaların yaş ortalaması 41,59±11,79 (31-56), beden kitle indeksi ortalaması 30,02±4,77 idi. Hastaların şikâyet süreleri ortalaması 48,93±45,32 ay, günlük ped kullanımı ortalaması 3,92±2,39'du. İdiopatik AAM tedavisi için her hastaya 100IU Botoks uygulaması 20 bölgeye yapıldı. Tedaviden 12 hafta sonra hastaların OABSS skorlarında anlamlı iyileşme izlendi (10,32±3,01'e 4,68±2,21; p<0,001). FSFI skorları incelendiğinde işlemden 12 hafta sonra FSFI-istek, uyarılma, doyum ve ağrı alt grupları ile toplam FSFI skorunda anlamlı iyileşme olduğu izlendi. Tedavi sonrası değerlendirmede hastaların %94,73'ü tedaviden memnundu. İki hastada idrar retansiyonu gerçekleşti. Sonuç: Çalışmamız sonucunda, intravezikal botoks enjeksiyonlarının AAM'li kadınlarda cinsel fonksiyonu iyileştirebileceği gösterilmiştir. Botoks enjeksiyonunun cinsel fonksiyonlar üzerine etkilerinin daha iyi değerlendirilmesi için konu ile ilgili daha geniş çalışmalara ihtiyaç vardır.

Anahtar Kelimeler: Aşırı aktif mesane; botoks; kadın cinsel fonksiyonu; sıkışma tipi idrar kaçırma
REFERENCES:
  1. Zachariou A, Mamoulakis C, Filiponi M, Dimitriadis F, Giannakis J, Skouros S, et al. The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study. BMC Urol. 2018;18(1):61. [Crossref]  [PubMed]  [PMC] 
  2. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5-26. [Crossref]  [PubMed] 
  3. Banakhar MA, Al-Shaiji TF, Hassouna MM. Pathophysiology of overactive bladder. Int Urogynecol J. 2012;23(8):975-82. [Crossref]  [PubMed] 
  4. Agarwal A, Eryuzlu LN, Cartwright R, Thorlund K, Tammela TL, Guyatt GH, et al. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur Urol. 2014;65(6):1211-7. [Crossref]  [PubMed]  [PMC] 
  5. Sinclair AJ, Ramsay IN. The psychosocial impact of urinary incontinence in women. The Obstetrician & Gynaecologist. 2011;13(3):143-8. [Crossref] 
  6. Andersson KE, Chapple CR, Cardozo L, Cruz F, Hashim H, Michel MC, et al. Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence. Curr Opin Urol. 2009;19(4):380-94. [Crossref]  [PubMed] 
  7. Coyne KS, Sexton CC, Thompson C, Kopp ZS, Milsom I, Kaplan SA. The impact of OAB on sexual health in men and women: results from EpiLUTS. J Sex Med. 2011;8(6):1603-15. [Crossref]  [PubMed] 
  8. Gaziev G, Topazio L, Iacovelli V, Asimakopoulos A, Di Santo A, De Nunzio C, et al. Percutaneous Tibial Nerve Stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review. BMC Urol. 2013;13:61. [Crossref]  [PubMed]  [PMC] 
  9. Musco S, Serati M, Lombardi G, Lumi E, Parisi AI, Del Popolo G, et al. Percutaneous tibial nerve stimulation improves female sexual function in women with overactive bladder syndrome. J Sex Med. 2016;13(2):238-42. [Crossref]  [PubMed] 
  10. Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, et al; EMBARK Study Group. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: Results of a phase 3, randomized, placebo controlled trial. J Urol. 2017;197 (2S):S216-S223. [PubMed] 
  11. Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, et al. Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score. Urology. 2006;68(2): 318-23. [Crossref]  [PubMed] 
  12. Culha MG, Degirmentepe RB, Ozbir S, Cakir SS, Homma Y. Turkish validation of the overactive bladder symptom score (OABSS) and evaluation of mirabegron treatment response. Int Urogynecol J. 2019;30(12):2121-26. [Crossref]  [PubMed] 
  13. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191-208. [Crossref]  [PubMed] 
  14. Aygin D, Aslan F. The Turkish adaptation of the Female Sexual Function Index [Kadın Cinsel İşlev Ölçeği'nin Türkçeye uyarlaması]. Turkiye Klinikleri Journal of Medical Sciences. 2005;25(3):393-9. [Link] 
  15. Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31(1):1-20. [Crossref]  [PubMed] 
  16. Di Marco J, De Broglie C, Manceau P, Weglinski L, Le Breton F, Verrollet D, et al. Les anticholinergiques ne modifient pas la fonction sexuelle chez les patientes atteintes de sclérose en plaques [Anticholinergics do not affect the sexual function in women diagnosed with multiple sclerosis]. Prog Urol. 2016;26(4):226-9. French. [Crossref]  [PubMed] 
  17. Dursun P, Dogan NU, Kolusari A, Dogan S, Ugur MG, Komurcu O, et al. Differences in geographical distribution and risk factors for urinary incontinence in Turkey: analysis of 6,473 women. Urol Int. 2014;92(2):209-14. [Crossref]  [PubMed] 
  18. Kocak I, Okyay P, Dundar M, Erol H, Beser E. Female urinary incontinence in the west of Turkey: prevalence, risk factors and impact on quality of life. Eur Urol. 2005;48(4):634-41. [Crossref]  [PubMed] 
  19. Sarici H, Ozgur BC, Telli O, Doluoglu OG, Eroglu M, Bozkurt S. The prevalence of overactive bladder syndrome and urinary incontinence in a Turkish women population; associated risk factors and effect on Quality of life. Urologia. 2016; 83(2): 93-8. [Crossref]  [PubMed] 
  20. Cakir SS, Degirmentepe RB, Atalay HA, Canat HL, Ozbir S, Culha MG, et al. The effect of overactive bladder treatment with anticholinergics on female sexual function in women: a prospective observational study. Int Urol Nephrol. 2019;51(1): 27-32. [Crossref]  [PubMed] 
  21. Chapple C, Sievert KD, MacDiarmid S, Khullar V, Radziszewski P, Nardo C, et al. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2013;64(2):249-56. [Crossref]  [PubMed] 
  22. Nitti VW, Ginsberg D, Sievert KD, Sussman D, Radomski S, Sand P, et al; 191622-096 Investigators. durable efficacy and safety of long-term onabotulinumtoxina treatment in patients with overactive bladder syndrome: final results of a 3.5-year study. J Urol. 2016;196(3):791-800. [PubMed] 
  23. Miotla P, Cartwright R, Skorupska K, Bogusiewicz M, Markut-Miotla E, Futyma K, et al. Impact of intravesical onabotulinumtoxinA on sexual function in women with OAB. Neurourol Urodyn. 2017; 36(6):1564-9. [Crossref]  [PubMed] 
  24. Balzarro M, Rubilotta E, Braga A, Bassi S, Processali T, Artibani W, et al. OnabotulinumtoxinA detrusor injection improves female sexual function in women with overactive bladder wet syndrome. Eur J Obstet Gynecol Reprod Biol. 2018;225:228-31. [Crossref]  [PubMed] 

.: Up To Date

.: Process List

Login



Contact


Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com